1
BACKGROUND : Calcitriol therapy suppresses serum levels of parathyroid hormone ( PTH ) in patients with renal failure but has several drawbacks , including hypercalcemia and / or marked suppression of bone turnover , which may lead to adynamic bone disease .
 Chemical: Calcitriol; Disease: renal failure; Disease: hypercalcemia; Disease: suppression of bone turnover; Disease: adynamic bone disease
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: Calcitriol; Disease: renal failure; Disease: hypercalcemia; Disease: suppression of bone turnover; Disease: adynamic bone disease